BamSEC and AlphaSense Join Forces
Learn More

ANI Pharmaceuticals Inc.

NASDAQ: ANIP    
Share price (11/4/24): $56.01    
Market cap (11/4/24): $1.178 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 17 pages Second Amended and Restated Bylaws of ANI Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 29 pages ANI Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 11 pages Amended and Restated Bylaws of ANI Pharmaceuticals, Inc. a Delaware Corporation
12/34/56
EX-3.1
from 10-Q 11 pages Certificate of Amendment of the Restated Certificate of Incorporation of Biosante Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Amendment of the Restated Certificate of Incorporation of Biosante Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of the Restated Certificate of Incorporation of Biosante Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 16 pages Amended and Restated Bylaws of Biosante Pharmaceuticals, Inc. a Delaware Corporation
12/34/56
EX-3.1
from 8-K 7 pages Restated Certificate of Incorporation of Biosante Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-A12B 1 page Certificate of Amendment of the Amended and Restated Certificate of Incorporation of Biosante Pharmaceuticals, Inc
12/34/56
EX-3.2
from SB-2 ~10 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from SB-2 ~10 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.2
from 10SB12G ~10 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 10SB12G ~20 pages Articles of Incorporation or Bylaws
12/34/56